While previous reports showed that RelB/p52 complexes promote GBM progression20–23, we strikingly found that over 80% of GBMs lost one allele of the NFKB2 (p100/p52), but almost 30% of GBMs have RelB allele gains (Fig. 2j). The gene discussed is NFKB2; the disease is glioblastoma.